Covered recipient · General Payments record
RAFFI DERSARKISSIAN
General Payments · PY2018–2023
$1,760.98
- Reported across 50 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $236.17 | 5 |
| Education | $16.90 | 2 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $178.16 | 3 |
| Galderma Laboratories, L.P. | $55.21 | 3 |
| MERZ NORTH AMERICA, INC. | $19.70 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (7)
Sorted by paying entity, then date · as published by CMS
Program year 2023 20182019202020212022
Record-level detail is published for PY2023; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $8.45 | 05/19/2023 | Education | Undisputed | 01/23/2026 | 996647655 | CMS |
| AbbVie Inc. | $8.45 | 05/19/2023 | Education | Undisputed | 01/23/2026 | 996647661 | CMS |
| AbbVie Inc. | $161.26 | 09/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996647665 | CMS |
| Galderma Laboratories, L.P. | $20.71 | 03/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1059691287 | CMS |
| Galderma Laboratories, L.P. | $20.23 | 05/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1059691289 | CMS |
| Galderma Laboratories, L.P. | $14.27 | 06/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1059691293 | CMS |
| Merz North America, Inc. | $19.70 | 12/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1051026283 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.